News

The Food and Drug Administration’s Center for Tobacco Products (“CTP”) has released a strategic plan intended to guide the Center’s activity for the next five years.

On January 31 and February 1, the Reagan-Udall Foundation for the FDA, will hold a virtual public workshop, “Advancing Psychedelic Clinical Study DesignExternal Link Disclaimer.” This meeting will bring together researchers, regulated industry, and…

In February of this year, Vapor Voice published my reflections on my past 11 years affiliated with the vapor industry. And while many would say that the vapor industry has been a roller coaster, I remain firm in my belief that a place for…

It remains a frustrating business environment. The vaping segment has survived despite setbacks in 2023 and continues growing as a global market. However, divergent regulatory perspectives on vaping’s harm reduction potential continue to hinder its…

Americans deserve to know how many calories we’re ordering when we order restaurant meals. FDA regulations are clear: chain restaurants with 20 or more locations across the U.S. are required to post calories on their menus, including “menus on the…

A bipartisan trio of U.S. senators has sent a letter to FDA Commissioner Robert Califf, urging him to reform the agency’s tobacco product application process, and asking him to explain and clarify the FDA’s approach to nicotine product regulation. Read…

It’s been 18 months since the FDA began studying problems in its Human Foods Program and an update from the agency says it will take more time to implement changes. The head of the Food and Drug Administration said on Dec. 13 that he is “hopeful” that…

Today, the U.S. Food and Drug Administration is providing an update on its efforts to create a unified Human Foods Program (HFP) and new Office of Regulatory Affairs (ORA) model, including additional details about the proposed structure, status of…

NMPF extolled the FARM antibiotic stewardship program in comments filed with the FDA on Oct.

Just over a year after joining FDA as the agency’s top scientist, Namandjé Bumpus will rise to second in command as principal deputy commissioner early next year – replacing Janet Woodcock who, after nearly 40 years as a leader within the agency,…